Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-07

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's generic carboprost tromethamine under an Original Application (ANDA) for postpartum hemorrhage and termination of pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)